Zynex Inc. Expected to Earn FY2017 Earnings of $0.21 Per Share (ZYXI)

Zynex Inc. (OTCMKTS:ZYXI) – Equities research analysts at Seethru Equity lifted their FY2017 EPS estimates for shares of Zynex in a report issued on Wednesday. Seethru Equity analyst A. Tandon now forecasts that the company will post earnings per share of $0.21 for the year, up from their prior forecast of $0.20.

Zynex (OTCMKTS:ZYXI) last posted its quarterly earnings data on Monday, November 13th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.01. Zynex had a net margin of 24.10% and a negative return on equity of 248.78%. The company had revenue of $6.82 million for the quarter, compared to the consensus estimate of $5.52 million.

Other analysts have also recently issued research reports about the stock. Zacks Investment Research raised shares of Zynex from a “hold” rating to a “buy” rating and set a $3.25 target price on the stock in a research note on Thursday, November 23rd. ValuEngine cut shares of Zynex from a “buy” rating to a “hold” rating in a research note on Tuesday, October 31st.

Zynex (ZYXI) opened at $3.70 on Thursday. The stock has a market cap of $119.84, a PE ratio of 28.46 and a beta of -0.10. Zynex has a twelve month low of $0.25 and a twelve month high of $4.00. The company has a current ratio of 1.27, a quick ratio of 1.19 and a debt-to-equity ratio of 0.02.

ILLEGAL ACTIVITY NOTICE: “Zynex Inc. Expected to Earn FY2017 Earnings of $0.21 Per Share (ZYXI)” was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of international copyright & trademark laws. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/01/18/zynex-inc-expected-to-earn-fy2017-earnings-of-0-21-per-share-zyxi.html.

Zynex Company Profile

Zynex, Inc operates through the Electrotherapy and Pain Management Products segment. The Company conducts its business through its subsidiaries and the operating subsidiary is Zynex Medical, Inc (ZMI). Its other subsidiaries include Zynex Monitoring Solutions, Inc (ZMS) and Zynex Europe, ApS (ZEU). ZMI designs, manufactures and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation.

Receive News & Ratings for Zynex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zynex and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply